Royce & Associates LP Lannett CO Inc Transaction History

Royce & Associates LP

$10.5 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$2.91 - $4.83 $119,702 - $198,682	-41,135 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$4.17 - $5.74 $48,192 - $66,337	-11,557 Reduced 21.93%	41,135 $192,000
Q1 2021 May 10, 2021	SELL	$5.28 - $9.64 $18,849 - $34,414	-3,570 Reduced 6.35%	52,692 $278,000
Q4 2020 Feb 08, 2021	SELL	$5.75 - $7.13 $86,209 - $106,900	-14,993 Reduced 21.04%	56,262 $367,000
Q3 2020 Nov 12, 2020	BUY	$4.9 - $7.12 $38,656 - $56,169	7,889 Added 12.45%	71,255 $435,000
Q2 2020 Aug 07, 2020	SELL	$6.43 - $9.86 $134,573 - $206,359	-20,929 Reduced 24.83%	63,366 $460,000
Q1 2020 May 12, 2020	SELL	$6.36 - $10.05 $46,408 - $73,334	-7,297 Reduced 7.97%	84,295 $586,000
Q4 2019 Feb 06, 2020	BUY	$8.49 - $12.81 $57,282 - $86,429	6,747 Added 7.95%	91,592 $808,000
Q3 2019 Nov 13, 2019	BUY	$5.58 - $14.47 $29,568 - $76,676	5,299 Added 6.66%	84,845 $950,000
Q2 2019 Aug 12, 2019	BUY	$5.22 - $9.08 $187,418 - $326,008	35,904 Added 82.27%	79,546 $482,000
Q1 2019 May 09, 2019	BUY	$5.35 - $9.82 $207,301 - $380,505	38,748 Added 791.74%	43,642 $343,000
Q4 2018 Feb 11, 2019	SELL	$3.43 - $6.19 $3,303 - $5,960	-963 Reduced 16.44%	4,894 $24,000
Q3 2018 Nov 13, 2018	BUY	$4.75 - $14.5 $22,211 - $67,802	4,676 Added 395.94%	5,857 $28,000
Q2 2018 Aug 09, 2018	BUY	$13.3 - $17.45 $6,477 - $8,498	487 Added 70.17%	1,181 $16,000
Q1 2018 May 14, 2018	BUY	$14.7 - $24.95 $4,380 - $7,435	298 Added 75.25%	694 $11,000
Q4 2017 Feb 09, 2018	SELL	$19.9 - $29.25 $3,860 - $5,674	-194 Reduced 32.88%	396 $9,000
Q3 2017 Nov 13, 2017	BUY	$15.1 - $19.25 $8,909 - $11,357	590	590 $11,000

Others Institutions Holding LCI

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About LANNETT CO INC

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

More about LCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Account